+1-888-308-5802     
News Contact Us

Medical devices firm Quanta Dialysis raises $48M in new funding round

Author : Sunil Hebbalkar | Published Date : 2019-07-30 

The funds are reported to support the United Kingdom commercial launch and FDA 510 (k) submission later in 2019.

UK-based Quanta Dialysis Technologies Ltd, has reportedly announced that it has successfully raised an amount of USD 48 million in the initial closing of its Series C funding round.

The first round was initiated by a Swiss owned family office in amalgamation with investing partners btov and led parallelly by Wellington Partners & Seroba Life Sciences, along with contribution from other existing investors. It has been claimed that the profits would be used to fund the United Kingdom commercial launch of SC+ and a 510(k) offer to the FDA later this year.

John E. Milad, the CEO of Quanta was reportedly quoted stating that the company was excited to launch its upgraded SC+ haemodialysis system to its first viable users in the UK by the end of this year. John further added that the support from both the investors, the existing and the newly appointed, has been commendable and will help the company in achieving its vision to help more dialysis patients in UK and beyond.

Christian Schütz, an investing partner claimed that with approximately 3.5 million dialysis patients being present globally, the company is confident that the updated system SC+ will provide much-needed result to help health systems deliver best value for money along with improving the lives of the patients.

As per the industry experts, the necessity of providing innovation in personal dialysis is becoming progressively vital. With its exclusive, state-of-the-art dialysis system designed explicitly for patient use, Quanta is ideally figured to bind the industry trends. 

SC+ is a mini, easy to use and powerful haemodialysis system developed to provide greater flexibility around the patient’s management and receive their dialysis remedy.

Quanta Dialysis Technologies headquartered in the UK, is a British medical technology firm involved in the development of individual haemodialysis system to better the lives of dialysis patients through innovation.

19-year old btov Partners, is a European venture capital firm concentrating on digital and industrial technologies.

Source credits: https://www.globenewswire.com/news-release/2019/07/29/1892601/0/en/Quanta-Raises-48-million-in-Series-C-Funding-Round.html

 

About Author

Sunil Hebbalkar

Sunil Hebbalkar

Sunil Hebbalkar currently works as a content writer for fractovia.org and other portals. A post graduate in mechanical design engineering, he nurtures a passion for writing articles related to myriad industry verticals such as the technology, automotive, and healthcare sectors. When free, Sunil pursues his interest in cycling, reading, and sketching. He can be contacted at- [email protected] | https://twitter.com/HSuniel

Related News

Del Monte to shut its Sleepy Eye plant & lay-off all employees on site

Published Date: 2019-08-23         Author: Sunil Hebbalkar

The Sleepy Eye plant closure would be waving hundreds of seasonal jobs and 69 full time jobs.   This closure is just a part of the greater vision of Del Monte’s parent company, Del Monte Pacific ­Limited based in Singapore, to close or sell most of its U.S. assets. Del Mon... Read More

Del Monte to shut its Sleepy Eye plant & lay-off all employees on site

Published Date: 2019-08-22         Author: Sunil Hebbalkar

The Sleepy Eye plant closure would be waving hundreds of seasonal jobs and 69 full time jobs.   This closure is just a part of the greater vision of Del Monte’s parent company, Del Monte Pacific ­Limited based in Singapore, to close or sell most of its U.S. assets. Del Mon... Read More

Hyundai Motor halts production subject to tough market conditions

Published Date: 2019-08-19         Author: Sunil Hebbalkar

The carmaker has declared no production days for some departments due to slowdown in the automobile sector. Engine Shop-1 and Engine Shop-2 are expected to face the no production days for ten and nice shifts respectively. The nation's second largest car-maker Hyundai Motors, India has ... Read More

© 2019 Fractovia. All Rights Reserved